XOMA Royalty Corporation declared quarterly dividends on its Series A and Series B Preferred Stock, with redemption of all outstanding preferred shares at $25 per share on July 14, 2026. The redemption is tied to the pending merger with Ligand Pharmaceuticals, with CVR distribution record date set for July 13, 2026.